Industrializable Synthesis of Fmoc-Ala-Thr-OH Pseudodipeptide as a Key Intermediate of Peptide Drugs

Abstract

A new process for industrially synthesizing Fmoc-Ala-Thr-OH pseudodipeptide, which is a key intermediate for the synthesis of peptide drugs, is presented in four steps in overall 46% yield from Fmoc-L-Ala-OH. The process did not use column chromatography, and the characteristic of dipeptide salting with some organic base was cleverly utilized for purification. The suitable organic base for forming salt with the dipeptide was found after screening, and finally the synthesis was completed by recrystallization. The whole synthesis process is beneficial to industrial production and cost control. The purity of the product was over 99%.

Key words

synthesis - pseudodipeptide - drugs - recrystallization - industrial

Publication History

Received: 23 February 2025

Accepted after revision: 07 May 2025

Accepted Manuscript online:
07 May 2025

Article published online:
11 June 2025

• References

• 1 Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC. N. Engl. J. Med. 2022; 387: 205
• 2 Yule LR, Bower RL, Kaur H, Kowalczyk R, Haya DL, Brimble MA. Org. Biomol. Chem. 2016; 14: 5238
• 3a Nowick JS. Acc. Chem. Res. 2008; 41: 1319
• 3b Nowick JS, Chung DM, Maitra K, Maitra S, Stigers KD, Sun Y. J. Am. Chem. Soc. 2000; 122: 7654
• 3c Auer S, Kashchiev D. Phys. Rev. Lett. 2008; 101: 168105
• 3d Gunasekaran K, Ramakrishnan C, Balaram P. Protein Engng. 1997; 10: 1131
• 4a Kozminski P, Gniazdowska E, Fuks L, Oszczak A. J. Radioanal Nucl. Chem. 2012; 292: 67
• 4b Anderson GW, Zimmerman J, Callah FM. J. Am. Chem. Soc. 1964; 86: 1839
• 5a Sosnovsky G, Baysals M, Erciyas E. J. Pharm. Sci. 1994; 83: 999
• 5b Widdison WC, Ponte JF, Coccia JA, Lanieri L, Setiady Y, Dong L, Skaletskaya A, Hong EE, Wu R, Qiu Q.-F, Singh R, Salomon P, Fishkin N, Harris L, Maloney EK, Kovtun Y, Veale K, Wilhelm SD, Audette CA, Costoplus JA, Chari RV. J. Bioconjug Chem. 2015; 26: 2261
• 6a Abedini A, Raleigh DP. Org. Lett. 2005; 7: 693
• 6b Joseph R, Padilla MM, Garner P. Tetrahedron Lett. 2015; 56: 4302
• 6c Wohr T, Wahl F, Nefzi A, Rohwedder B, Sato T, Sun XC, Mutter M. J. Am. Chem. Soc. 1996; 118: 9218
• 7 Schöwe MJ, Keiper O, Unverzagt C, Wittmann V. Chem. Eur. J. 2019; 25: 15759
• 8 Jackson RF. W, Moore RJ, Dexter CS. J. Org. Chem. 1998; 63: 7875
• 9 Haug BE, Rich DH. Org. Lett. 2004; 6: 4783
• 10a Staros JV, Wright RW, Swingle DM. Anal. Biochem. 1986; 156: 220
• 10b Grabarek Z, Gergely J. Anal. Biochem. 1990; 185: 131
• 11a Jadhav SV, Bandyopadhyay A, Benke SN, Mali SM, Gopi HN. Org. Biomol. Chem. 2011; 9: 4182
• 11b Zhang Y, Chen L, Wang R.-Y, Li T.-J, Shi X.-L. Patent 104987382A, 2015